Detalhe da pesquisa
1.
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023.
Clin Infect Dis
; 78(2): 338-348, 2024 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37633258
2.
Post-recovery health domain scores among outpatients by SARS-CoV-2 testing status during the pre-Delta period.
BMC Infect Dis
; 24(1): 300, 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38454352
3.
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022.
J Infect Dis
; 227(8): 961-969, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36415904
4.
Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness.
Clin Infect Dis
; 76(9): 1615-1625, 2023 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36611252
5.
Vaccine Effectiveness Against Acute Respiratory Illness Hospitalizations for Influenza-Associated Pneumonia During the 2015-2016 to 2017-2018 Seasons: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
Clin Infect Dis
; 74(8): 1329-1337, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320171
6.
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022.
MMWR Morb Mortal Wkly Rep
; 71(29): 931-939, 2022 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35862287
7.
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022.
MMWR Morb Mortal Wkly Rep
; 71(13): 495-502, 2022 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35358170
8.
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022.
MMWR Morb Mortal Wkly Rep
; 71(42): 1335-1342, 2022 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36264840
9.
Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011-2012 to 2016-2017.
Clin Infect Dis
; 72(7): 1147-1157, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32006430
10.
Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021.
MMWR Morb Mortal Wkly Rep
; 70(44): 1539-1544, 2021 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735425
11.
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021.
MMWR Morb Mortal Wkly Rep
; 70(44): 1553-1559, 2021 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735426
12.
Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019.
MMWR Morb Mortal Wkly Rep
; 68(6): 135-139, 2019 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30763298
13.
Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults-Nine States, January-September 2021.
Am J Transplant
; 22(1): 306-314, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34967121
14.
Risk of COVID-19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric Disorders.
Influenza Other Respir Viruses
; 18(3): e13269, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38494192
15.
Effect of programmed intermittent epidural bolus protocol on physician-administered rescue boluses of labor analgesia.
Proc (Bayl Univ Med Cent)
; 36(6): 687-691, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37829233
16.
Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021-February 2022, VISION Network: a retrospective cohort study.
Lancet Reg Health Am
; 23: 100530, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37333688
17.
Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods.
JAMA Netw Open
; 6(3): e232598, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36920396
18.
Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents.
Pediatrics
; 151(5)2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37026401
19.
Burden of medically attended influenza infection and cases averted by vaccination - United States, 2016/17 through 2018/19 influenza seasons.
Vaccine
; 40(52): 7703-7708, 2022 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36379754
20.
Vaccine-associated attenuation of subjective severity among outpatients with influenza.
Vaccine
; 40(32): 4322-4327, 2022 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35710506